Moneycontrol PRO
HomeNewsIndiaCoronavirus India: First COVID-19 reinfection case in Bengaluru; 27-year-old tests positive again within a month

Coronavirus India: First COVID-19 reinfection case in Bengaluru; 27-year-old tests positive again within a month

Doctors at Fortis Hospital, Bengaluru claim this is first reported case of reinfection in the city.

September 06, 2020 / 17:01 IST
Representative Image

A private hospital has reported that a 27-year-old woman from Bengaluru tested positive again nearly a month after she was treated and discharged from the hospital. Doctors at Fortis Hospital, claim that this could be the first reported case of reinfection in the city.

“On July 6, the patient was symptomatic. She reported with fever, cough, and sore throat and had tested positive. She was admitted at the hospital and recovered well. A repeat test was conducted on her, which turned out to be negative, after which she was discharged on July 24,” Pratik Patil, consultant, Infectious Diseases, at the hospital, told The Hindu on September 5.

“However, in the last week of August, she developed mild symptoms again and tested positive again. Both the times she did not have severe disease. This is possibly the first reported case of COVID-19 reinfection in Bengaluru. She has recovered well this time too and is being discharged. We have not done a repeat COVID-19 test before discharge this time as per the new discharge policy,” he said.

In August, University of Hong Kong scientists had claimed to have the first evidence of someone being reinfected with the virus that causes COVID-19 after genetic tests showed that a 33-year-old man returning from a trip to Spain in mid-August had a different strain of the coronavirus than the one he was found infected with in March.

The same month, at a press briefing, the Indian Council of Medical Research (ICMR)Director-General Balram Bhargava said the Hong Kong case is a stray example and the reinfection can depend upon various factors.

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

"We have read with interest the reports of reinfection in one case in Hong Kong. We are learning more and more about the disease as we go ahead. It can depend on several factors, one can be related to the patient itself, how is his immunity, how was his immune status, was it compromised. It can also depend upon the virus, whether the virus has mutated or turned virulent," he said, reported news agency PTI.

However, only one case of re-infection has been reported and it is very rare for viral infections, he said.

Citing the example of measles, he said once it affects, it gives lifelong immunity.

But rarely does one can get the measles a second time.

"Similarly, this is a stray example, but for this disease, we are trying to find out. We need to find out how long the immunity lasts. We need to closely follow it up, but at the same time we don't need to be alarmed immensely about it," Bhargava said.

Meanwhile, India's COVID-19 tally of cases went past 41 lakh with a record 90,632 people being infected in a day, while 31,80,865 people have recuperated so far pushing the national recovery rate to 77.32 percent on September 6, according to the Union Health Ministry data.

With inputs from PTI

Moneycontrol News
first published: Sep 6, 2020 05:01 pm

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Subscribe to Tech Newsletters

  • On Saturdays

    Find the best of Al News in one place, specially curated for you every weekend.

  • Daily-Weekdays

    Stay on top of the latest tech trends and biggest startup news.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347